Syneos Health, Inc. (SYNH) is a publicly traded company in the Healthcare sector, operating within the Medical - Diagnostics & Research industry. The company is headquartered in Morrisville, NC, United States. The current CEO is Michelle Keefe.
SYNH has IPO date of 2014-11-07, 28,768 full-time employees, listed on the NASDAQ Global Select, a market capitalization of $4.46B.
Syneos Health, Inc. is a global biopharmaceutical outsourcing solutions provider headquartered in Morrisville, North Carolina, serving clients across North America, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. The company operates through two primary segments: Clinical Solutions, which offers comprehensive development services for diagnostics, drugs, biologics, devices, and digital therapeutics across Phase I to IV clinical trials, including regulatory consulting, patient recruitment, clinical monitoring, and trial diversity support; and Commercial Solutions, which provides commercialization services including deployment strategies, communications solutions such as public relations and medical communications, and consulting services to pharmaceutical, biotechnology, and healthcare companies. With a history of innovation in the biopharmaceutical services industry, Syneos Health has established itself as a key partner for companies navigating drug development and market commercialization.
